inforMED
MalfunctionLCP

TINA-QUANT HBALC GEN. 3

Received Jun 16, 2022 · Event occurred Jun 1, 2022

Report 1823260-2022-01758 · MDR key 14715740

Device

Generic name

Assay, Glycosylated Hemoglobin

Manufacturer

Roche Diagnostics

Model number

HBA1C TQ G3

Catalog number

05336163190

Lot number

59190201

Product problems

  • High Test Results
  • High Test Results

Patient

68 YR · Female

  • No Clinical Signs, Symptoms or Conditions
  • No Clinical Signs, Symptoms or Conditions

Narrative

Description of Event or Problem

THE INITIAL REPORTER RECEIVED QUESTIONABLE HBA1C TQ GEN.3 RESULTS ON A COBAS INTEGRA 400 PLUS ANALYZER. DUE TO A CLIENT QUESTIONING REPORTED HBA1C RESULTS, THE REPORTER REPEATED PREVIOUS PATIENT SAMPLES ON THE SAME ANALYZER. FOR PATIENT SAMPLE #(B)(6), THE INITIAL HBA1C RESULT WAS 8.1%. THE REPEAT HBA1C RESULT WAS 6.4%. THE INITIAL RESULT WAS REPORTED OUTSIDE OF THE LABORATORY. THE SAMPLE WAS COLLECTED AND INITIALLY RUN ON (B)(6) 2022. THE REPEAT TEST WAS PERFORMED ON THE SAME SAMPLE AND ANALYZER ON (B)(6) 2022. THE INSTRUMENT SERIAL NUMBER IS (B)(4).

Additional Manufacturer Narrative

THE FIELD SERVICE ENGINEER (FSE) PERFORMED A PRECISION STUDY THAT WAS ACCEPTABLE. THE FSE FOUND THAT WASH PROBE C HAD FAILED THE THROUGHPUT CHECK AND WAS NOT DISPENSING FLUID. HE REPLACED TWO VALVES, RESEATED AND REPLACED BOARDS, AND REPLACED THE CASSETTE SENSE LOCK MODULE. THE CUSTOMER SUCCESSFULLY PERFORMED CALIBRATION AND QC. AS THE QC RECOVERY WAS WITHIN 2SD, THERE WAS NO INDICATION OF A PERFORMANCE ISSUE OF THE REAGENT. THE SERVICE ACTIONS PERFORMED BY THE FSE RESOLVED THE ISSUE.